Skadden is advising Edwards Lifesciences, while Ropes & Gray is providing legal counsel to BD on the deal. Edwards Lifesciences has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Fulcrum Therapeutics on the transaction. Fulcrum Therapeutics, Inc. (Fulcrum) (Nasdaq: FULC) announced it has entered into a collaboration and license agreement with...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Chiesi Group on the transaction, and Latham & Watkins advised Gossamer Bio. Chiesi Group announced it has entered into a global collaboration...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Ginkgo Bioworks in the transaction. Ginkgo Bioworks (NYSE: DNA) announced its acquisition of AgBiome’s platform assets in agricultural biologics. The assets will be integrated into...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the transaction. Ginkgo Bioworks (NYSE: DNA) announced the acquisition of Patch Biosciences, which has built an AI platform for sequence design that...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented ImmunoGen in the deal. ImmunoGen, Inc. announced a multi-target license and option agreement to research novel, first-in-class ADCs with ImmunoBiochem Corporation on the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer on the deal. Pfizer announced a strategic collaboration with Flagship Pioneering to create a new pipeline of innovative medicines. The collaboration...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton and Ropes & Gray are serving as legal advisor to Advent and Warburg Pincus, while Sullivan & Cromwell is serving as...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Provention Bio, Inc. on the deal. Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced a sales agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented HUTCHMED on the deal. HUTCHMED (China) Limited and its subsidiary, HUTCHMED Limited announced an exclusive worldwide license agreement with Japan’s largest drugmaker Takeda...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised ImmunoGen on the deal. ImmunoGen, a leader in the field of antibody-drug conjugates for cancer treatment, announced a research collaboration with Biosion USA,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, announced the closing a transaction with Bayer for a...
You must be a Standard 1 Year member to access this content.
